Cellectar Biosciences, Inc. Payments for Merger Related Costs
Cellectar Biosciences, Inc. (CLRB) reported Payments for Merger Related Costs of $296.21 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2013-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForMergerRelatedCosts · last filed 2013-03-28
- Cellectar Biosciences, Inc. payments for merger related costs for the quarter ending 2011-03-31 was $250.43K.
- Cellectar Biosciences, Inc. payments for merger related costs for fiscal 2011 was $296.21K.
| Period end | Payments for Merger Related Costs 3 month | Payments for Merger Related Costs 12 month | Payments for Merger Related Costs 12 month as first filed |
|---|---|---|---|
| 2011-12-31 | $296.21K 10-K · filed 2013-03-28 | $250.00K 10-Q · filed 2012-08-09 | |
| 2011-03-31 | $250.43K 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |